United States · FDA National Drug Code directory
diltiazem hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-248_d52d40db-f91a-49ea-ac2f-88a56f429421
- Product NDC
- 50742-248
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- diltiazem hydrochloride
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190614
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-248-05) · 50742-248-05
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-248-10) · 50742-248-10
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-248-30) · 50742-248-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-248-90) · 50742-248-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →